0001104659-23-039363.txt : 20230330 0001104659-23-039363.hdr.sgml : 20230330 20230330201602 ACCESSION NUMBER: 0001104659-23-039363 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230328 FILED AS OF DATE: 20230330 DATE AS OF CHANGE: 20230330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SILBER ALLAN C CENTRAL INDEX KEY: 0001009161 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39373 FILM NUMBER: 23782487 MAIL ADDRESS: STREET 1: C/O COUNSEL CORPORATION STREET 2: 700 - 1 TORONTO ST. CITY: TORONTO STATE: A6 ZIP: M5C 2V6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: POINT Biopharma Global Inc. CENTRAL INDEX KEY: 0001811764 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850800493 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (317) 543-9957 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FORMER COMPANY: FORMER CONFORMED NAME: Therapeutics Acquisition Corp. DATE OF NAME CHANGE: 20200511 4 1 tm2311087-6_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-03-28 0 0001811764 POINT Biopharma Global Inc. PNT 0001009161 SILBER ALLAN C 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 1 1 1 0 Executive Chairman 0 Stock Option (Right to Buy) 6.78 2023-03-28 4 A 0 537322 0.00 A 2029-03-28 Common Stock 537322 537322 D The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter. /s/ William L. Demers, by Power of Attorney for Allan C. Silber 2023-03-30